The 20 Best Breast Cancer in Men Doctors Near Me in Bronx, NY

Dr. Hershman is Witten Family Professor of Medicine, American Cancer Society Professor of Medicine and Epidemiology, chief of the division of hematology/oncology, and deputy director of the Herbert Irving Comprehensive Cancer Center at Columbia University. She completed her medical degree at the Albert Einstein College of Medicine, and completed her internal medicine and oncology fellowship training at Columbia University Medical Center, where she served as Chief Resident. During that time she completed a Master's degree in Biostatistics at the Mailman School of Public Health. She has developed nationally recognized expertise in breast cancer treatment, prevention, and survivorship.Dr. Hershman has also developed a comprehensive multidisciplinary program to study ways of improving cancer care delivery (CCD), reducing disparities and designing studies to improve the quality of life and quality of care in breast cancer survivors. She has received funding from the American Society of Clinical Oncology, American Cancer Society, Department of Defense, Breast Cancer Research Foundation, PCORI, and the National Cancer Institute. She currently has mentored numerous faculty members who have been granted mentored career development awards, and has received the Women Who Conquer Cancer Mentorship Award and the CUIMC Mentor of the Year Award. Dr. Hershman has published over 450 scientific articles and has received several awards including the highly prestigious Advanced Clinical Research Award in Breast Cancer from the American Society of Clinical Oncology, the Advanced Medical Achievement Award from the Avon Foundation and a Giants in Cancer Care Award.She has several national leadership roles in oncology. As vice chair of the SWOG Cancer Research Network she oversees the NCI's Community Oncology Research Programs (NCORP) research portfolio, which includes prevention and epidemiology, cancer care delivery, symptom control and quality of life, and survivorship trials. Within ASCO she was selected to participate in the first Leadership Development Program and has been the Chair of the Grants Selection Committee, Chair of the ASCO Quality Care Symposium and has been a member of multiple committees and task-forces. She is on the editorial board for the Journal of Clinical Oncology and is an Associate Editor at the Journal of the National Cancer Institute. Dr. Hershman is rated as a Distinguished provider by MediFind in the treatment of Breast Cancer in Men. She is also highly rated in 20 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Febrile Neutropenia, Inflammatory Breast Cancer, Vulvectomy, and Salpingo-Oophorectomy. Dr. Hershman is board certified in Internal Medicine and Medical Oncology. Dr. Hershman is currently accepting new patients.

My research is focused on breast cancer management, and on care delivery and support for breast cancer patients. Dr. Makower is rated as an Experienced provider by MediFind in the treatment of Breast Cancer in Men. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Pleuropulmonary Blastoma.

Sheldon Marc Feldman, MD, is Chief, Breast Surgery and Breast Surgical Oncology, Professor, Surgery and Director, Breast Cancer Services at Montefiore Einstein. His clinical focus includes breast cancer, oncoplastic surgery with an emphasis on optimizing breast conservation, nipple-sparing mastectomy, minimally invasive diagnosis and treatment, intraoperative radiation, targeted tumor ablation, lymphedema prevention, and complementary integrative holistic care with an emphasis on physician-patient communication. Dr. Feldman is rated as an Experienced provider by MediFind in the treatment of Breast Cancer in Men. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Intraductal Papilloma, Breast Cancer, Inflammatory Breast Cancer, Mastectomy, and Lymphadenectomy.

Sun Young Oh, MD, is an Oncologist and Assistant Professor, Oncology and Medicine at Montefiore Einstein. Her clinical focus is on medical oncology and the systemic treatment of breast cancer. Dr. Oh is rated as an Experienced provider by MediFind in the treatment of Breast Cancer in Men. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Inflammatory Breast Cancer.

Ruth Samson is a General Surgeon practicing medicine in Bronx, New York. Dr. Samson is rated as an Experienced provider by MediFind in the treatment of Breast Cancer in Men. Her clinical expertise encompasses Breast Enlargement In Males and Breast Cancer in Men.

Craig Larsen is a General Surgeon practicing medicine in Bronx, New York. Dr. Larsen is rated as an Experienced provider by MediFind in the treatment of Breast Cancer in Men. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Giant Mammary Hamartoma, Fibroadenoma, Intraductal Papilloma, Ileostomy, and Mastectomy. Dr. Larsen is board certified in American Board Of Surgery.

Nella Shapiro is a General Surgeon practicing medicine in Bronx, New York. Dr. Shapiro is rated as an Experienced provider by MediFind in the treatment of Breast Cancer in Men. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Intraductal Papilloma, Giant Mammary Hamartoma, and Lymphadenectomy.

Sandeep Malik is an Internal Medicine provider practicing medicine in Bronx, New York. Dr. Malik is rated as an Experienced provider by MediFind in the treatment of Breast Cancer in Men. He is also highly rated in 34 other conditions, according to our data. His clinical expertise encompasses Malabsorption, Deep Vein Thrombosis, Essential Thrombocythemia, and Intraductal Papilloma.

Katherine D. Crew, M.D., M.S. is an the Avon Products Foundation Professor of Medicine and Epidemiology at the NewYork-Presbyterian/Columbia University Medical Center, co-associate director for education and training and co-director of the Cancer Research Training and Education Core (CRTEC) at the Herbert Irving Comprehensive Cancer Center (HICCC). In addition to treating patients with breast cancer and women at high-risk for breast cancer, Dr. Crew has a long-standing interest and background in the design of clinical trials and observational studies in breast cancer prevention and survivorship.She serves as the Director of the Clinical Breast Cancer Prevention Program at Columbia University and Executive Officer for the SWOG Prevention, Screening, and Surveillance and Cancer Care Delivery Committees. She is a member of multiple national consortia and societies in oncology, including the American Association for Cancer Research and American Society of Clinical Oncology, and is an editorial board member of the Journal of Clinical Oncology. Dr. Crew received her undergraduate B.S. in Biochemistry from Brown University, where she graduated Magna Cum Laude. She received her M.D. from Columbia University College of Physicians and Surgeons and her M.S. from Columbia University School of Public Health. She completed her Internal Medicine residency and Medical Oncology fellowship at NewYork-Presbyterian/Columbia University Medical Center. Dr. Crew is rated as an Advanced provider by MediFind in the treatment of Breast Cancer in Men. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and Salpingo-Oophorectomy. Dr. Crew is board certified in Internal Medicine and Medical Oncology. Dr. Crew is currently accepting new patients.

Andrew Seidman is an Oncologist practicing medicine in New York, New York. Dr. Seidman is rated as a Distinguished provider by MediFind in the treatment of Breast Cancer in Men. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Breast Cancer in Men, Paget Disease of the Breast, and Inflammatory Breast Cancer. Dr. Seidman is currently accepting new patients.

Larry Norton is an Oncologist practicing medicine in New York, New York. Dr. Norton is rated as a Distinguished provider by MediFind in the treatment of Breast Cancer in Men. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Triple-Negative Breast Cancer, and Breast Cancer in Men. Dr. Norton is currently accepting new patients.

Vered Stearns is an Oncologist practicing medicine in New York, New York. Dr. Stearns is rated as a Distinguished provider by MediFind in the treatment of Breast Cancer in Men. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, Inflammatory Breast Cancer, and Paget Disease of the Breast.

Bonnie Reichman is an Oncologist practicing medicine in New York, New York. Dr. Reichman is rated as an Advanced provider by MediFind in the treatment of Breast Cancer in Men. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Intraductal Papilloma, and Inflammatory Breast Cancer. Dr. Reichman is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine/Medical Oncology.

David Horowitz, M.D. is a board-certified radiation oncologist and Associate Professor of Radiation Oncology at New York-Presbyterian/Columbia University Irving Medical Center. His clinical focus is on gastrointestinal cancers, lymphoma and breast cancer, and his research interests focus on the development of novel ways to deliver precision radiation therapy to hard-to-treat cancers. Dr. Horowitz received his B.A. from Dartmouth College and his M.D. from the Johns Hopkins University School of Medicine, during which time he completed a research fellowship in the Department of Radiation Oncology and Molecular Radiation Sciences. He completed his internal medicine internship training at the Georgetown University/Washington Hospital Center after which he completed his radiation oncology training at New York Presbyterian Hospital (Columbia University Medical Center Campus), where he additionally served as Chief Resident.Dr. Horowitz has developed the use of multiple radiation techniques at the Columbia University Irving Medical Center to best help patients with cancer receive the most effective treatments while minimizing potential side effects. These include stereotactic body radiation therapy (SBRT), stereotactic radiosurgery, hypofractionated ablative radiation therapy, intensity modulated radiation therapy, image-guided radiation therapy, intraoperative radiotherapy, brachytherapy, total body irradiation, and total skin electron beam therapy. As a member of the Pancreas Center at Columbia, Dr. Horowitz is part of a multidisciplinary team that brings expertise from multiple specialties, including surgery, medical oncology and radiology to the care of complex patients with pancreas cancer.Outside of his clinical duties, Dr. Horowitz serves as Director of Medical Student Education in the Department of Radiation Oncology, as well as the Associate Program Director for the department's residency program. Dr. Horowitz has mentored numerous medical students and residents, with multiple mentees receiving competitive research grants from the NIH, American Medical Association, and Gold Foundation. For a list of publications, please visit Pubmed.gov. Dr. Horowitz is rated as an Experienced provider by MediFind in the treatment of Breast Cancer in Men. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Familial Pancreatic Cancer, Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), and Breast Cancer. Dr. Horowitz is board certified in Radiation Oncology. Dr. Horowitz is currently accepting new patients.

Lisa A. Kachnic, MD, one of the nation’s leading radiation oncologists and a pioneer of new approaches to optimize the effectiveness of radiation therapy, is the Chu H. Chang Professor and Chief of the Department of Radiation Oncology at Columbia University Vagelos College of Physicians and Surgeons (VP&S) and Chief of the Radiation Oncology Service at NewYork-Presbyterian/Columbia University Irving Medical Center (CUIMC). She also serves as Associate Director of Radiation Oncology and Science in the Herbert Irving Comprehensive Cancer Center (HICCC). Dr. Kachnic’s combined focus on clinical excellence, technological innovation, and patient-centered research continues to advance the field of radiation oncology, which has resulted in over 150 publications and over $17 million in research support from major federal and non-profit agencies. She is widely recognized for gastrointestinal research that has transformed the standard of care for several cancers by integrating novel radiation delivery techniques. A past president of the American Board of Radiology, Dr. Kachnic is internationally known for her clinical trial leadership positions in the National Cancer Institute and its cooperative group research bases. She currently serves as Vice Chair of the Radiation Oncology Committee and Co-Chair of the Ano-Rectal Subcommittee for the SWOG Cancer Research Network research base, for which she is the multi-modality executive officer, as well as NRG Oncology’s Associate PI of their NCORP (NCI Community Oncology Research Program) and chair of the NCORP’s Cancer Control Committee. At Columbia, she is contact PI of Columbia’s NCORP and is co-PI of several NCI training grants for residents and early career faculty. Dr. Kachnic is rated as an Experienced provider by MediFind in the treatment of Breast Cancer in Men. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Anal Cancer, Anaplastic Large Cell Lymphoma, Esophageal Cancer, and T-Cell Lymphoma. Dr. Kachnic is board certified in Radiation Oncology. Dr. Kachnic is currently accepting new patients.

Martin Oster is an Oncologist practicing medicine in New York, New York. Dr. Oster is rated as an Advanced provider by MediFind in the treatment of Breast Cancer in Men. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Angiosarcoma, and Head and Neck Squamous Cell Carcinoma (HNSCC).

Dr. Bret Taback is a nationally recognized surgical oncologist in the New York-Presbyterian/Columbia University Irving Medical Center department of surgery. Dr. Taback is a leader in the clinical management of melanoma, sarcoma and skin/soft tissue tumor surgery. Dr. Taback is the Director of the Melanoma and Sarcoma Program and Director of the Breast Surgery Fellowship. Dr. Taback received his MD degree at Tufts University School of Medicine in Boston , and completed his general surgery residency at Brown University, Rhode Island Hospital. During that time he completed a Basic Science Research Fellowship at Beth Israel Deaconess Medical Center, Harvard Medical School in Boston. Following this, he completed a fellowship in Complex Surgical Oncology at the John Wayne Cancer Institute, Santa Monica, California. Dr. Taback is a member of a number of organizations and societies including Society of Surgical Oncology, American Society of Clinical Oncology and the American Association for Cancer Research. He is also a Fellow of the American College of Surgeons. He has published and authored numerous peer review manuscripts, abstracts and presentations, as well as book chapters over the years in notable publications such as Annals of Surgery, Annals of Surgical Oncology, Cancer Research, Clinical Cancer Research and the Journal of the National Cancer Institute. He is a clinical investigator with SWOG and Alliance for clinical trials. Dr. Taback has served on numerous hospital committees including tumor boards, Institutional Review Boards, Oncology Operations Council and is the American College of Surgeon’s Commission on Cancer Physician Liaison for NYP Hospital. Most recently, Dr. Taback is a noted Castle Connolly Top Doctor. Dr. Taback is rated as an Experienced provider by MediFind in the treatment of Breast Cancer in Men. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Melanoma, Paget Disease of the Breast, Mastectomy, and Lymphadenectomy. Dr. Taback is board certified in Surgery. Dr. Taback is currently accepting new patients.

Meghna S. Trivedi, MD, MS cares for patients diagnosed with breast cancer. Dr. Trivedi received her medical degree from the University of Maryland School of Medicine, and completed her residency at the University of Pennsylvania. She went on to complete her fellowship in hematology/oncology at Columbia University.Dr. Trivedi co-leads the Hereditary Breast and Ovarian Cancer Program, a comprehensive, multi-disciplinary initiative aimed at screening, preventing, diagnosing, and treating hereditary breast and ovarian cancer. This innovative program brings together the resources of a world-renowned academic institution, including cutting-edge genomic testing, clinical trials, and experts in hereditary cancers across different specialties.Dr. Trivedi’s research and care expertise also includes cancer genetics and genomics, precision medicine, and chemotherapy induced peripheral neuropathy. She is the principal investigator on several clinical trials, and has authored numerous publications in leading peer-reviewed journals. Dr. Trivedi is a member of the American Society of Clinical Oncologists and SWOG. Dr. Trivedi is rated as an Experienced provider by MediFind in the treatment of Breast Cancer in Men. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, Salpingo-Oophorectomy, and Thrombectomy. Dr. Trivedi is board certified in Internal Medicine. Dr. Trivedi is currently accepting new patients.

Myron M. Studner Professor of Cancer Research and Professor of Medicine and Epidemiology at Columbia University, Associate Director for Population Science, Leader of the Prevention, Control, and Disparities Program for the Herbert Irving Comprehensive Cancer Center at Columbia, and Co-Director of the Cancer Prevention Center of New York Presbyterian Hospital Dr. Neugut is a medical oncologist with a particular interest in gastroIntestinal tract cancers, especially of colorectal and gasteric cancers. Under the auspices of Columbia's MD/PhD program, he received his MD and a PhD in Pathobiology in 1977. He did his training in Internal Medicine at the Albert Einstein College of Medicine and fellowship in Medical Oncology at Memorial Sloan-Kettering Cancer Center. He returned to Columbia University as an Andrew Mellon Fellow in Epidemiology and Medicine to obtain an MPH in Epidemiology in 1983. Dr. Neugut then joined the faculty at Columbia University with appointments in Medicine and Epidemiology.As both a practicing medical oncologist and cancer epidemiologist, Dr. Alfred Neugut's major interests have been on GI tract cancers, notably the epidemiology of colorectal adenomas and cancer, as well as colonoscopic screening. He serves as co-principal investigator of the Long Island Breast Cancer Study Project, a large multi-center effort to explore environmental causes of breast cancer on Long Island. Most recently, his efforts have focused on more clinical topics, such as the epidemiology of second malignancies and the use of chemotherapy and radiation therapy among elderly cancer patients. Dr. Neugut focuses a great deal on racial disparities in incidence and survival from cancer and, in particular, variations across subgroups of people of African descent. He leads two large training grants in cancer-related population sciences that together fund 15 pre and postdoctoral trainees in cancer epidemiology, biostatistics, and environmental health sciences, and serves as a mentor to a number of junior faculty. Dr. Neugut is rated as an Experienced provider by MediFind in the treatment of Breast Cancer in Men. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Breast Cancer, Familial Colorectal Cancer, Endoscopy, and Colonoscopy. Dr. Neugut is board certified in Internal Medicine and Medical Oncology. Dr. Neugut is currently accepting new patients.

As an Assistant Professor of Medicine within the Division of Hematology/Oncology at Columbia University Irving Medical Center (CUIMC), Dr. McGuinness specializes in the care of patients with breast cancer or who are at high risk of developing breast cancer. She is currently involved in patient care, clinical research, and education. Her research interests include the evaluation of novel imaging-based tools to refine breast cancer risk prediction and to predict which patients receive benefit from breast cancer therapies. As part of this work, she collaborates closely with computer scientists, data scientists, and breast radiologists at Columbia. She also serves as the principal investigator for multiple clinical trials at CUIMC that evaluate novel treatments for patients with breast cancer. She is actively involved in the SWOG Cancer Research Network, and serves as a member of the SWOG Prevention and Epidemiology and Breast Committees, as well as the SWOG Breast Translational Medicine Working Group.Dr. McGuinness received her bachelor of arts in Biology magna cum laude from Williams College, and her medical degree with Honor from Baylor College of Medicine, where she was elected to the Gold Humanism Honor Society. She completed both her Internal Medicine residency and Hematology/Oncology fellowship at Columbia University Irving Medical Center, during which she also served as Chief Fellow and completed a Postdoctoral Research Fellowship in Biomedical Informatics. Dr. McGuinness is the recipient of multiple career development awards from the Conquer Cancer Foundation/American Society of Clinical Oncology and the Susan G. Komen Foundation, as well as a TRANSFORM KL2 Mentored Career Development Award. Dr. Mcguinness is rated as an Experienced provider by MediFind in the treatment of Breast Cancer in Men. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, Paget Disease of the Breast, and HER-2 Positive Breast Cancer. Dr. Mcguinness is currently accepting new patients.